UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)

Phase 1

Withdrawn

Conditions: Myelodysplastic Syndromes

Interventions: Drug: Omacetaxine
Drug: Azacitidine
Drug: G-CSF

First Posted Date: 2016-07-18

Last Posted Date: 2017-05-03

Lead Sponsor: University of Florida

Registration Number: NCT02835794

Locations: 🇺🇸
University of Florida Health Shands Cancer Hospital, Gainesville, Florida, United States

Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea

Not Applicable

Completed

Conditions: Sleep Apnea, Obstructive
Snoring

Interventions: Device: Genioglossis Strength Trainer
Device: Placebo Genioglossis Strength Trainer

First Posted Date: 2016-07-15

Last Posted Date: 2020-02-06

Lead Sponsor: University of Florida

Target Recruit Count: 23

Registration Number: NCT02834767

Locations: 🇺🇸
University of Florida Sleep Center, Gainesville, Florida, United States

Novel Coating to Minimize Bacterial Adhesions and Tooth Wear in Denture Acrylic

Completed

Conditions: Denture Stomatitis
Wear of Denture Teeth

Interventions: Device: PECVD coating

First Posted Date: 2016-07-15

Last Posted Date: 2020-07-23

Lead Sponsor: University of Florida

Target Recruit Count: 17

Registration Number: NCT02834832

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Evaluation of Ketamine and Multi-modal Analgesics

Withdrawn

Conditions: Pain

Interventions: Drug: Ketamine
Drug: Lidocaine
Drug: Acetaminophen
Drug: Neurontin

First Posted Date: 2016-06-28

Last Posted Date: 2019-07-31

Lead Sponsor: University of Florida

Registration Number: NCT02815111

OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)

Not Applicable

Completed

Conditions: High Blood Pressure

Interventions: Other: HTN PRA App
Other: Blood Sample

First Posted Date: 2016-06-27

Last Posted Date: 2018-10-25

Lead Sponsor: University of Florida

Target Recruit Count: 47

Registration Number: NCT02814552

Locations: 🇺🇸
UF Health Family Medicine, Macclenny, Florida, United States
🇺🇸
UF Health Family Medicine - Old Town, Old Town, Florida, United States
🇺🇸
Tallahassee Memorial Hospital, Tallahassee, Florida, United States

Identification of Clinically Relevant Markers of Deep Brain Stimulation Electrode Impedance

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Other: Impedance measurements

First Posted Date: 2016-06-09

Last Posted Date: 2018-05-15

Lead Sponsor: University of Florida

Target Recruit Count: 6

Registration Number: NCT02794233

Locations: 🇺🇸
University of Florida, Center for Movement Disorders and Neurorestoration, Gainesville, Florida, United States

Image Parkinson's Disease Progression Study

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Other: Placebo
Drug: Rasagiline
Device: Magnetic Resonance Imaging
Device: functional Magnetic Resonance Imaging
Other: Physical Function Performance Test

First Posted Date: 2016-06-02

Last Posted Date: 2023-09-06

Lead Sponsor: University of Florida

Target Recruit Count: 96

Registration Number: NCT02789020

Locations: 🇺🇸
Laboratory for Rehabilitation Neuroscience, Gainesville, Florida, United States

Study of Oral Treatments for Hepatitis C

Phase 4

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only)
Drug: SOF/LDV (sofosbuvir/ledipasvir)
Drug: EBR/GZR (elbasvir/grazoprevir)
Drug: Ribavirin

First Posted Date: 2016-06-01

Last Posted Date: 2021-12-06

Lead Sponsor: University of Florida

Target Recruit Count: 1275

Registration Number: NCT02786537

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
University of Florida, Jacksonville, Jacksonville, Florida, United States
🇺🇸
Internal Medicine Associates of Wellstar Atlanta Medical Center, Atlanta, Georgia, United States

and more 34 locations

Antibiotic "Dysbiosis" in Preterm Infants

Phase 2

Completed

Conditions: Bacteremia
Chronic Lung Disease
Enterocolitis, Necrotizing
Ileal Perforation
Bronchopulmonary Dysplasia
Periventricular Leukomalacia
Intraventricular Hemorrhage

Interventions: Drug: Antibiotic
Other: Gastric fluid
Other: Breast milk
Other: Stool samples
Drug: Antibiotics

First Posted Date: 2016-05-27

Last Posted Date: 2024-06-05

Lead Sponsor: University of Florida

Target Recruit Count: 98

Registration Number: NCT02784821

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Steroids in Children Hospitalized With Asthma

Phase 4

Terminated

Conditions: Asthma
Status Asthmaticus
Wheezes

Interventions: Drug: Dexamethasone
Drug: Prednisone

First Posted Date: 2016-05-23

Last Posted Date: 2019-06-21

Lead Sponsor: University of Florida

Target Recruit Count: 6

Registration Number: NCT02780479

Locations: 🇺🇸
Wolfson Children Hospital, Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy